HealthCare Global Enterprises Limited (NSE:HCG)
India · Delayed Price · Currency is INR 570.85
+5.30 (0.94%)
Nov 12, 2026, 3:29 PM IST
NSE:HCG Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 85,229 | 78,414 | 75,541 | 47,056 | 36,511 | 37,519 | |
Market Cap Growth | -20.74% | 3.80% | 60.53% | 28.88% | -2.69% | 57.11% |
Enterprise Value | 100,905 | 94,807 | 88,656 | 55,427 | 44,015 | 44,685 |
Last Close Price | 575.75 | 525.20 | 538.77 | 335.77 | 260.84 | 268.24 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 744.13 | 570.07 | 170.10 | 97.72 | 124.40 | 69.83 |
Forward PE | 43.07 | 65.80 | 79.65 | 62.39 | 47.99 | 125.83 |
PS Ratio | 3.14 | 3.08 | 3.40 | 2.46 | 2.15 | 2.68 |
PB Ratio | 5.94 | 5.56 | 7.63 | 5.44 | 4.20 | 4.25 |
P/TBV Ratio | 9.12 | 8.60 | 17.03 | 8.21 | 5.53 | 5.69 |
P/FCF Ratio | 285.45 | 142.60 | 69.79 | 47.58 | 30.85 | 25.20 |
P/OCF Ratio | 28.98 | 22.59 | 23.82 | 16.54 | 14.51 | 17.05 |
PEG Ratio | 0.51 | 1.86 | 1.59 | 0.71 | 4.48 | 4.48 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 3.72 | 3.73 | 3.99 | 2.90 | 2.60 | 3.20 |
EV/EBITDA Ratio | 20.47 | 24.41 | 28.58 | 20.75 | 18.55 | 25.05 |
EV/EBIT Ratio | 42.54 | 41.62 | 50.61 | 35.65 | 32.48 | 56.18 |
EV/FCF Ratio | 337.95 | 172.41 | 81.91 | 56.04 | 37.19 | 30.01 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 1.12 | 1.23 | 1.86 | 1.47 | 1.04 | 1.03 |
Debt / EBITDA Ratio | 3.28 | 3.72 | 4.82 | 3.93 | 3.11 | 4.03 |
Debt / FCF Ratio | 53.90 | 31.56 | 16.97 | 12.89 | 7.61 | 6.14 |
Net Debt / Equity Ratio | 1.03 | 0.84 | 1.50 | 1.12 | 0.81 | 0.80 |
Net Debt / EBITDA Ratio | 3.59 | 3.06 | 4.80 | 3.64 | 2.97 | 3.98 |
Net Debt / FCF Ratio | 49.63 | 21.60 | 13.76 | 9.82 | 5.95 | 4.77 |
Asset Turnover | 0.74 | 0.68 | 0.71 | 0.76 | 0.75 | 0.66 |
Inventory Turnover | 20.52 | 20.82 | 21.57 | 21.36 | 22.70 | 25.28 |
Quick Ratio | 0.70 | 0.96 | 0.72 | 0.81 | 0.88 | 0.96 |
Current Ratio | 0.91 | 1.12 | 0.81 | 0.91 | 1.02 | 1.07 |
Return on Equity (ROE) | 1.80% | 1.90% | 5.27% | 4.77% | 2.01% | 4.87% |
Return on Assets (ROA) | 4.01% | 3.81% | 3.50% | 3.87% | 3.74% | 2.34% |
Return on Invested Capital (ROIC) | 4.80% | 7.59% | 6.96% | 5.56% | 3.36% | 2.26% |
Return on Capital Employed (ROCE) | 8.20% | 7.80% | 7.00% | 7.90% | 7.80% | 4.50% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 0.13% | 0.18% | 0.59% | 1.02% | 0.80% | 1.43% |
FCF Yield | 0.35% | 0.70% | 1.43% | 2.10% | 3.24% | 3.97% |
Buyback Yield / Dilution | -3.40% | -0.28% | -1.40% | -0.50% | -3.35% | -18.95% |